Chu Chung K. 4
4 · Atea Pharmaceuticals, Inc. · Filed Nov 3, 2020
Insider Transaction Report
Form 4
Chu Chung K.
10% Owner
Transactions
- Conversion
Series A Convertible Preferred Stock
2020-11-03−100,000→ 0 total→ Common Stock (100,000 underlying) - Conversion
Series C Convertible Preferred Stock
2020-11-03−43,859→ 0 total→ Common Stock (43,859 underlying) - Conversion
Series B Convertible Preferred Stock
2020-11-03−33,003→ 0 total→ Common Stock (33,003 underlying) - Conversion
Common Stock
2020-11-03+176,862→ 1,176,862 total
Footnotes (1)
- [F1]The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.